Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Trial Profile

COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2018

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms COSMOS
  • Sponsors AbbVie
  • Most Recent Events

    • 28 Nov 2018 Planned End Date changed from 14 Dec 2018 to 31 Jan 2019.
    • 28 Nov 2018 Planned primary completion date changed from 14 Dec 2018 to 31 Jan 2019.
    • 22 May 2018 Planned number of patients changed from 28 to 58.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top